Probiotics to help gut health after stem cell transplant
Part of Blood & lymphatic, Digestive system, Immune system & allergy clinical trials.
This trial tests whether a special probiotic made from the patient's own gut bacteria and their donor's can help fix gut problems caused by a complication called graft-versus-host disease (aGVHD) after a stem cell transplant. It might help patients who are over 50 and scheduled for a specific type of transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age must be over 50, for any gender
- You must be scheduled for a half-matched stem cell transplant from a family donor
- You should be generally healthy enough for transplant, with an ECOG score of 2 or lower
- You must agree to take part and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a probiotic called Bacillus coagulans can help prevent or treat acute graft-versus-host disease, a common complication after donor stem cell transplants. It is for adults with blood cancers or severe aplastic anemia who received a specific type of transplant conditioning.
This study tests whether a fecal transplant (FMT) can help treat gut graft-versus-host disease (gut GVHD), a condition where donated immune cells attack the intestines. If you have gut GVHD and meet age requirements, you may be eligible to receive this treatment in the trial.
This early-phase study tests a prebiotic (galacto-oligosaccharide) to see if it can lower or prevent gut inflammation caused by acute graft-versus-host disease (acute GVHD) after a stem cell transplant. If you’re scheduled for an allogeneic transplant, participating may help researchers find safer ways to protect your gut.
This trial studies a treatment made from donor gut microbes to help prevent a common complication after a transplant called acute graft-versus-host disease (aGVHD). It may help by improving the balance and variety of gut bacteria during recovery after haploidentical transplant.
This Phase 2 study tests an oral “fecal microbiotherapy” treatment given before and around an allogeneic (donor) stem-cell transplant to help prevent transplant-related complications. It may help by improving gut and immune function during the high-risk transplant period.
This trial tests whether transplanting healthy gut bacteria can help children whose bodies are rejecting donor stem cells in their intestines and who haven't responded to high-dose steroids. The goal is to reduce intestinal damage and improve outcomes after bone marrow transplant.
Hear when a new Acute Graft Versus Host Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.